News for 'US Generics'

Joshimath sank 5.4cm in just 12 days, show ISRO's satellite images

Joshimath sank 5.4cm in just 12 days, show ISRO's satellite images

Rediff.com13 Jan 2023

The subsidence zone is located at central Joshimath only including the Army Helipad and Narsingh temple, the satellite images revealed.

Glenmark buys certain OTC drugs from Wockhardt in US

Glenmark buys certain OTC drugs from Wockhardt in US

Rediff.com28 Jun 2022

Glenmark Pharmaceuticals Ltd on Tuesday said it has acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd in the US. The acquisition by the company's fully-owned subsidiary Glenmark Pharmaceuticals Inc, USA includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine, the company said in a statement. The company, however, did not disclose the financial details.

What GenZers Like/Hate On First Dates

What GenZers Like/Hate On First Dates

Rediff.com25 Apr 2023

It's important for GenZers to know what they are getting themselves into: If you're going on a date, clearly state your intentions ahead of time! That way, there won't be any surprises that could disrupt the flow of the evening, alerts Sybil Shiddell, country manager India, Gleeden, a discreet extra marital dating Web site.

7 Ways To Craft A Perfect CV

7 Ways To Craft A Perfect CV

Rediff.com13 Jun 2023

No matter what field you work in or what stage of your career you are in, metrics-based data always augments your CV, alerts Neelabh Shukla, Chief Business Officer, MyCareernet.

Alone Review: Mohanlal's WORST Performance!

Alone Review: Mohanlal's WORST Performance!

Rediff.com16 Mar 2023

If you thought you loved Mohanlal and that you could watch him do anything for 120 minutes, Alone is your chance to put your love to the test, observes Mayur Sanap.

No CAA/NRC protest banners! IPL ticket advisory in four cities

No CAA/NRC protest banners! IPL ticket advisory in four cities

Rediff.com2 Apr 2023

Four cities, including, Delhi, Mohali, Hyderabad and Ahmedabad have been issued ticket advisories with fans being banned from carrying protest banners.

Despite high valuations, analysts put a 'buy' on Siemens

Despite high valuations, analysts put a 'buy' on Siemens

Rediff.com6 Mar 2023

Things are looking up for engineering firms and Siemens is likely to be one of the leading beneficiaries. Apart from the generic revival in activity, which is expected to continue through the 2023-24 financial year (FY24), the Budget has a strong infrastructure thrust, which works in Siemens' favour. The company reported a standalone Ebitda (earnings before interest, tax, depreciation and amortisation) of Rs 550 crore (up 66 per cent year-on-year or YoY) in Q1FY23 (Siemens follows the October-September accounting year).

India business to put a spring in pharma's step

India business to put a spring in pharma's step

Rediff.com26 Apr 2023

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.

Is GPT-4 Intelligent?

Is GPT-4 Intelligent?

Rediff.com3 May 2023

Overestimation of AI can lead to an excessive level of trust and the spread of disinformation. ChatGPT's replies are riddled with factual errors, hidden in eloquent, grammatically correct sentences. This leads to a hallucination of truth, explains Kumar Abishek.

Garmi Review: Yet Another Violent Show Set In UP

Garmi Review: Yet Another Violent Show Set In UP

Rediff.com21 Apr 2023

Of late, crime, politics, corruption and hate have been leaking out of every streaming platform. By the time Garmi drops, fatigue has already set in, observes Deepa Gahlot.

'A lot has been done between India and the US in the last two years than it was done before'

'A lot has been done between India and the US in the last two years than it was done before'

Rediff.com23 Jun 2023

'With Trump, the relationship was very transactional, whereas with President Biden it is very structured.'

Review: Bholaa Is Quite A Trip

Review: Bholaa Is Quite A Trip

Rediff.com30 Mar 2023

The real scene stealer of Ajay-Tabu's Fury Road is Deepak 'Deadly' Dobriyal, applauds Sukanya Verma.

10 Stocks To Invest For The Long Term

10 Stocks To Invest For The Long Term

Rediff.com11 Apr 2023

The third-quarter financials didn't excite market watchers. But equity investors can still make money if they invest in the right stocks.

Janhvi-Varun's Bawaal Trip Through Europe

Janhvi-Varun's Bawaal Trip Through Europe

Rediff.com31 Jul 2022

Janhvi Kapoor's latest film Bawaal has made her quite the globetrotter.

Generic flu drug threatens Tamiflu

Generic flu drug threatens Tamiflu

Rediff.com14 May 2009

An Indian pharmaceutical company is gearing up to sell a cheap version of the leading patented antiviral flu drug Tamiflu to emerging economies, in a move that will pitch intellectual property rights against affordable access to medicines.

El Nino effect: Agrochem companies may face near-term headwinds

El Nino effect: Agrochem companies may face near-term headwinds

Rediff.com6 Mar 2023

Domestic-focused agricultural chemical (agrochem) companies could face near-term headwinds, given the worries on the El Nio effect on monsoons, higher inventory, and pressure on margins. Some of these were reflected in the October-December quarter (third quarter, or Q3) results of companies and may impact them in the current quarter (fourth quarter, or Q4) as well. Nuvama Research pointed out that the sector witnessed mixed performance during the quarter as global agrochem and domestic fertiliser companies maintained growth momentum, while adverse agronomical conditions and excess channel inventory weighed on domestic market volume offtake.

9 Tips To Handle Valentine's Day

9 Tips To Handle Valentine's Day

Rediff.com8 Feb 2023

Valentine's day is nerve-wracking only because people make it so; stop putting pressure on yourself to make it perfect, suggests Ravi Mittal, CEO, Quack Quack, an online dating app.

SEE: PM gets emotional during interaction with PMBJP beneficiaries

SEE: PM gets emotional during interaction with PMBJP beneficiaries

Rediff.com7 Mar 2020

Prime Minister Narendra Modi on Saturday got emotional after interacting with one of the beneficiaries of Pradhan Mantri Bhartiya Janaushadhi Pariyojana who got paralysis attack a couple of years ago and is now recovering from the generic medicine provided under the scheme.

Strictly follow due procedure: SC on UP demolitions

Strictly follow due procedure: SC on UP demolitions

Rediff.com16 Jun 2022

We expect the authorities to strictly follow the due procedure under the law, the SC said.

Perfetti plays with generic themes

Perfetti plays with generic themes

Rediff.com20 Mar 2007

After the success of Lagey Raho for Alpenliebe, Perfetti is looking to play with generic themes and sticky tag-lines for Center Fresh as well.

Lupin aims to enter Chinese market in the next one year

Lupin aims to enter Chinese market in the next one year

Rediff.com8 Feb 2021

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.

Is Adani a Modi Crony?

Is Adani a Modi Crony?

Rediff.com11 Apr 2023

This State-corporate 'cooperation' didn't begin with the arrival of the Modi government.
Many of the big licences, contracts, and even environmental clearances for the Adani group had come in the UPA's time, points out Shekhar Gupta.

Ved Review: Nothing New To Surprise

Ved Review: Nothing New To Surprise

Rediff.com10 Jan 2023

The 'been there, seen that' feeling is so strong with Ved that it punctures any possibility of a compelling watch, Mayur Sanap tells us.

No, Friends is Not The Best Sitcom Ever!

No, Friends is Not The Best Sitcom Ever!

Rediff.com14 Jul 2023

'The pride of the devoted Seinfeld fan is that he happens to love a show that doesn't take his love for granted, so that even on repeat viewings he is never really sure what directions an episode might take,' observes Sreehari Nair.

Bhumi Gyaan: How Women Can Get What They Want

Bhumi Gyaan: How Women Can Get What They Want

Rediff.com15 Mar 2023

'Every woman should believe she is a lady killer because that's the only way she can gain the confidence to achieve whatever she wants in life.'

3 Indian pharma cos recall products in US market

3 Indian pharma cos recall products in US market

Rediff.com24 Apr 2022

Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Pharma is recalling a drug used to increase the production of natural tears in eyes. Similarly, Jubilant Cadista is recalling a drug which is used to treat different inflammatory conditions.

IUML member moves resolution in RS seeking Sachar report implementation

IUML member moves resolution in RS seeking Sachar report implementation

Rediff.com10 Feb 2023

A private member resolution seeking that the government implement the recommendations of the Sachar Committee report and other reports that have discussed the educational and social backwardness of Muslims and enact a legislation for the prevention of atrocities against minorities was moved in the Rajya Sabha on Friday.

9 Lies Told About Skincare

9 Lies Told About Skincare

Rediff.com9 Feb 2023

There seems to be a barrage of age-old blunders that people tend to commit in the name of skincare, says dermatologist Dr Batul Patel, director, The Bombay Skin Clinic.

Projects that harm Joshimath should be stopped: Badrinath head priest

Projects that harm Joshimath should be stopped: Badrinath head priest

Rediff.com15 Jan 2023

Talking to PTI, he said the development works should be implemented by protecting the lives of the people.

'A Lot Of Demand For Niche Talent'

'A Lot Of Demand For Niche Talent'

Rediff.com11 Aug 2022

'Generic skills are in abundance, but technological advancements have left staple skills redundant.' 'It is why employers are now looking for alternate sources of hiring -- deploying gig workers, looking at Tier 2 and Tier 3 cities for relevant talent.'

HC questions govt over poor infra for security at Subramanian Swamy's house

HC questions govt over poor infra for security at Subramanian Swamy's house

Rediff.com31 Oct 2022

The court was informed by the central government that a security review of Swamy's private house, where he would be residing after vacating the government-allotted bungalow, has been undertaken.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

Your Tax Queries Answered

Your Tax Queries Answered

Rediff.com23 Dec 2022

Anil Rego, CEO, Right Horizons, answers your personal income tax queries.

The Best Of Yash Chopra On OTT

The Best Of Yash Chopra On OTT

Rediff.com11 May 2023

Deepa Gahlot lists the most popular Yash Chopra films -- the ones he directed, not produced (yes, so that means no DDLJ) -- that can be watched on OTT.

IIT-Madras is India's Top University

IIT-Madras is India's Top University

Rediff.com15 Jul 2022

Seven Indian Institutes of Technology -- IIT-Madras, IIT-Bombay, IIT-Delhi, IIT-Kanpur, IIT-Kharagpur, IIT-Roorkee and IIT-Guwahati -- figured in the top 10 in the overall rankings.

Budget: Sitharaman promises 80 lakh houses under PMAY in 2022-23

Budget: Sitharaman promises 80 lakh houses under PMAY in 2022-23

Rediff.com1 Feb 2022

Finance Minister Nirmala Sitharaman on Tuesday announced allocation of whopping Rs 48,000 crore for completion of 80 lakh houses under the Pradhan Mantri Awas Yojana (PMAY), both rural and urban, during the next fiscal year. In her budget speech, the minister said: "In 2022-23, 80 lakh houses will be completed for the identified eligible beneficiaries of PM Awas Yojana, both rural and urban. Rs 48,000 crore is allocated for this purpose." The Centre would work with states for reduction of time required for all land and construction related approvals, for promoting affordable housing for middle-class and Economically Weaker Sections (EWS) in urban areas, she said.

Lupin sells Japan arm to Unison for Rs 3,702 cr

Lupin sells Japan arm to Unison for Rs 3,702 cr

Rediff.com12 Nov 2019

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India.

Personal info of Akasa Air's passengers leaked, airline informs CERT-In

Personal info of Akasa Air's passengers leaked, airline informs CERT-In

Rediff.com29 Aug 2022

Personal information such as name, gender, email address and phone numbers of some Akasa Air passengers has been leaked to "unauthorised individuals", the airline stated on Sunday. India's newest carrier said it self-reported this incident to Indian Computer Emergency Response Team CERT-In, which is the government-authorised nodal agency tasked to deal with matters of this nature. However, Akasa Air asserted that there was no "intentional hacking attempt, but that the situation was reported by a research expert through a journalist for which we are grateful".

Commission revises long form for M&As, changes effective from May 1

Commission revises long form for M&As, changes effective from May 1

Rediff.com5 Apr 2022

Companies planning merger and acquisition (M&A) will have to disclose the extent of "complementary linkages" among them and their impact on the market. This comes under the revised reporting requirements of the Competition Commission of India (CCI). The changes will take effect on May 1. Entities may also have to provide market-facing data of the past five years with respect to their market size, the market share of the parties, and also that of the competitors, along with customers and suppliers.

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Rediff.com27 Apr 2021

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.